Publishing is Hollywood's R&D

A studio cannot cheaply test whether an audience wants a story. A publisher can, because publishing a book costs a fraction of filming one, and the result is a market signal that somebody else paid for.

That is why option deals have become routine. Agents describe dramatic rights activity at a pace of roughly one deal a week in the trade listings, across a far wider range of titles than the prestige adaptations of a decade ago.

What gets optioned has shifted with it. The signal buyers act on is demonstrated readership rather than critical standing, which favours books with visible communities around them over books with good reviews and modest sales.

The route through social recommendation has become the clearest version of this. A title that sells persistently because readers keep telling each other about it has produced exactly the evidence a development executive cannot generate internally.

Self-published and fan-driven work now enters the pipeline for the same reason, which would have been unthinkable when acquisition ran through a small number of imprints and their taste.

An option is not a film, and the distinction matters more than the announcements suggest. Most options expire. The payment buys time and exclusivity, and the majority of what is optioned goes no further than a draft.

For authors that produces a strange economy. The option fee is often modest against the attention it generates, and the meaningful money arrives only if the project is made, which is the outcome the author controls least.

Format has also stopped being obvious at the point of sale. A novel might become a film, a limited series or a returning show, and the decision follows the buyer's slate rather than the shape of the book.

The limited series has absorbed the most, because it accommodates a plot that a two-hour film would have to gut and does not require the invention a returning show needs after its source runs out.

Both industries have quietly reorganised around the arrangement. Publishers now weigh adaptation potential in acquisition, and studios treat the bestseller list as a slate that somebody else has already market-tested.